cancer clinical trials in kansas city, KS
|
University of Kansas Medical Center
Trial Locations University of Kansas Medical Center Providence Medical Center Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Prostate Cancer
|
|
Providence Medical Center
Kansas City, Kansas 66112 Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Leukemia
|
|
University of Kansas Hospital
Kansas City, Kansas 66160 Non-small Cell Lung Cancer
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Neoplasms, Breast
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Lymphoma
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Lung Cancer, Non-Small Cell
|
|
Kansas City VA Medical Center
Kansas City, Kansas 64128 Mycoses, Candidiasis, Invasive, Candidemia
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Prostate Cancer
|
|
Kansas City Cancer Centers - West
Kansas City, Kansas 66112 Bladder Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Lung Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Leukemia
|
|
Providence Medical Center
Kansas City, Kansas 66112 Recurrent Endometrial Carcinoma
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Xerostomia
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Neoplasms, Prostate, Prostate Cancer
|
|
GSK Investigational Site
Kansas City, Kansas 66160 Neoplasms, Breast, Breast Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
|
|
Providence Medical Center
Kansas City, Kansas 66112 Leukemia
|
|
Pfizer Investigational Site
Kansas City, Kansas 66112 Multiple Myeloma
|
|
Providence Medical Center
Kansas City, Kansas 66112 Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Neuroblastoma
|
|
University of Kansas Medical Center
Trial Locations University of Kansas Medical Center Kansas City Cancer Center-West Neuroendocrine Carcinoma
|
|
Kansas City Cancer Center
Kansas City, Kansas 66112 NSCLC
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
Providence Medical Center
Kansas City, Kansas 66112 Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Colorectal Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
|
|
Providence Medical Center
Kansas City, Kansas 66112 B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Lung Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Colorectal Cancer
|
|
Kansas City, Kansas 66160 Soft Tissue Sarcoma
|
|
Providence Medical Center
Kansas City, Kansas 66112 Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
|
|
ImClone Investigational Site
Kansas City, Kansas 66160 Metastatic Breast Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Primary Progressive Multiple Sclerosis
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Metastatic Breast Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Melanoma
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Trial Locations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Cancer Centers - West Extrahepatic Bile Duct Cancer, Gallbladder Cancer
|
|
Kansas University Cancer Center
Kansas City, Kansas 66160 Non Small Cell Lung Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Endometrial Cancer, Fatigue, Neurotoxicity
|
|
University of Kansas Medical Center
Trial Locations University of Kansas Medical Center Kansas City Cancer Center-West Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
|
|
University of Kansas Medical Center, Westwood Campus
Kansas City, Kansas 66205 Non-Hodgkins Lymphoma
|
|
The University of Kansas Cancer Center
Kansas City, Kansas 66160 Prostate Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
|
|
University of Kansas Hospital
Kansas City, Kansas 66160 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Breast Cancer
|
|
University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
|
|
Kansas City, Kansas 66160 Prostate Cancer
|
|
Kansas Cty Cancer Center - West
Kansas City, Kansas 66112 Breast Cancer
|
|
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas 66160-7353 Brain and Central Nervous System Tumors
|
|
Kansas City, Kansas 66160 Carcinoma, Hepatocellular
|
